Collaborators NCDC. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018;392(10152):1072–88.

Fabiani I, Chianca M, Aimo A, et al. Use of new and emerging cancer drugs: what the cardiologist needs to know. Eur Heart J. 2024;45(22):1971–87.

Article  PubMed  Google Scholar 

Mattioli R, Ilari A, Colotti B, et al. Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming. Mol Aspects Med. 2023;93:101205.

Article  CAS  PubMed  Google Scholar 

McGowan JV, Chung R, Maulik A, et al. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc Drugs Ther. 2017;31(1):63–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 4.2021. J Natl Compr Canc Ne. 2021;19(5):485–94.

Google Scholar 

Farías JG, Molina VM, Carrasco RA, et al. Antioxidant therapeutic strategies for cardiovascular conditions associated with oxidative stress. Nutrients. 2017;9(9):966.

Article  PubMed  PubMed Central  Google Scholar 

Narezkina A, Narayan HK, Zemljic-Harpf AE. Molecular mechanisms of anthracycline cardiovascular toxicity. Clin Sci (Lond). 2021;135(10):1311–32.

Article  PubMed  Google Scholar 

Davies KJ, Doroshow JH. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem. 1986;261(7):3060–7.

Article  CAS  PubMed  Google Scholar 

Doroshow JH, Davies KJ. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem. 1986;261(7):3068–74.

Article  CAS  PubMed  Google Scholar 

Zhao Y, McLaughlin D, Robinson E, et al. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with doxorubicin chemotherapy. Cancer Res. 2010;70(22):9287–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vermot A, Petit-Härtlein I, Smith SME, et al. NADPH Oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants (Basel). 2021;10(6):890.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prosser BL, Ward CW, Lederer WJ. X-ROS signaling: rapid mechano-chemo transduction in heart. Science. 2011;333(6048):1440–5.

Article  CAS  PubMed  Google Scholar 

Elnakish MT, Hassanain HH, Janssen PM, et al. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol. 2013;231(3):290–300.

Article  CAS  PubMed  Google Scholar 

Octavia Y, Tocchetti CG, Gabrielson KL, et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 2012;52(6):1213–25.

Article  CAS  PubMed  Google Scholar 

Wojnowski L, Kulle B, Schirmer M, et al. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation. 2005;112(24):3754–62.

Article  CAS  PubMed  Google Scholar 

Deng S, Kruger A, Kleschyov AL, et al. Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH. Free Radic Biol Med. 2007;42(4):466–73.

Article  CAS  PubMed  Google Scholar 

Roy R, Wilcox J, Webb AJ, et al. Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: Mechanisms and therapeutic potential. Int J Mol Sci. 2023;24(20):15200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukhopadhyay P, Rajesh M, Batkai S, et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol. 2009;296(5):H1466–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vasquez-Vivar J, Martasek P, Hogg N, et al. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry. 1997;36(38):11293–7.

Article  CAS  PubMed  Google Scholar 

Kalivendi SV, Kotamraju S, Zhao H, et al. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J Biol Chem. 2001;276(50):47266–76.

Article  CAS  PubMed  Google Scholar 

Wu S, Ko YS, Teng MS, et al. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol. 2002;34(12):1595–607.

Article  CAS  PubMed  Google Scholar 

Duquaine D, Hirsch GA, Chakrabarti A, et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase. Vasc Med. 2003;8(2):101–7.

Article  PubMed  Google Scholar 

Finkelman BS, Putt M, Wang T, et al. Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer. J Am Coll Cardiol. 2017;70(2):152–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tadokoro T, Ikeda M, Ide T, et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight. 2020;5(9):e132747.

Article  PubMed  PubMed Central  Google Scholar 

Myers CE, McGuire WP, Liss RH, et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 1977;197(4299):165–7.

Article  CAS  PubMed  Google Scholar 

Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: focusing on mitochondria. Redox Biol. 2015;4:193–9.

Article  CAS  PubMed  Google Scholar 

Ichikawa Y, Ghanefar M, Bayeva M, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest. 2014;124(2):617–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menon AV, Kim J. Iron promotes cardiac doxorubicin retention and toxicity through downregulation of the mitochondrial exporter ABCB8. Front Pharmacol. 2022;13:817951.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ikeda S, Matsushima S, Okabe K, et al. Blockade of L-type Ca(2+) channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-kappaB pathway. Sci Rep. 2019;9(1):9850.

Article  PubMed  PubMed Central  Google Scholar 

Kalivendi SV, Konorev EA, Cunningham S, et al. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem J. 2005;389(Pt 2):527–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tscheschner H, Meinhardt E, Schlegel P, et al. CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression. PLoS ONE. 2019;14(4):e0215992.

Article  CAS  PubMed  PubMed Central